JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Signaling Pathways

Signaling Pathways

A5354 Zonisamide

Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels

Summary: Antiepileptic with anticonvulsant and mechanistic effect

insoluble in H2O; ≥8.35 mg/mL
A3604 Mibefradil

Target: Voltage-gated Calcium Channels (CaV)

Summary: Calcium channel blocker

≥49.6 mg/mL
B1989 Nisoldipine

Target: Voltage-gated Calcium Channels (CaV)

Summary: calcium channel blocker
B1867 Verapamil HCl

1 Citation

Target: Voltage-gated Calcium Channels (CaV)

Summary: L-type calcium channel blocker

≥14.45 mg/mL
B1505 Epiandrosterone

Target: Voltage-gated Calcium Channels (CaV)

Summary: steroid hormone with weak androgenic activity
B2278 Ibutilide Fumarate

Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel

Summary: Class III antiarrhythmic agent

≥25.6 mg/mL
B1393 Nitrendipine

Target: Voltage-gated Calcium Channels (CaV)

Summary: Calcium channel blocker

insoluble in H2O; ≥13.7 mg/mL
B1410 Amlodipine

Target: Voltage-gated Calcium Channels (CaV)

Summary: Calcium channel blocker

insoluble in H2O; ≥17.7 mg/mL
B1572 Latrepirdine

Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor

Summary: Brain cell death inhibitor

insoluble in H2O; ≥19.62 mg/mL
B5351 SNX 482

Target: Voltage-gated Calcium Channels (CaV)

Summary: voltage-dependent R-type CaV2.3 calcium channel blocker

Soluble in H2O